Abstract
Small bioactive molecules are pre-requisite for any discovery discipline. Being aware of the fact that bioactivity is not randomly dispersed in the vast chemical space, chemists have been developing hypothesis that can provide access to these islands of bioactivities. Natural products have always been a source of inspiration and their structural motifs provide biologically relevant starting points for library synthesis. In addition to that, Diversity Oriented Synthesis (DOS) and Biology Oriented Synthesis (BIOS) have emerged other tools to guide synthesis design and help enrich compound collections in biological activities. Coherent developments in chem- and bioinformatic tools and in organic synthesis methods targeting efficient synthesis of compound collections are required to identify interesting molecules that can be employed as probes in chemical biology research and as drug candidates in medicinal chemistry investigations.
Keywords: Natural products, diversity oriented synthesis, biology oriented synthesis, compound libraries, small molecules, drug discovery, bioactivity, protein inhibitor, cyclopeptides, chemical space
Current Drug Targets
Title: Exploring and Exploiting Biologically Relevant Chemical Space
Volume: 12 Issue: 11
Author(s): Luc Eberhardt, Kamal Kumar and Herbert Waldmann
Affiliation:
Keywords: Natural products, diversity oriented synthesis, biology oriented synthesis, compound libraries, small molecules, drug discovery, bioactivity, protein inhibitor, cyclopeptides, chemical space
Abstract: Small bioactive molecules are pre-requisite for any discovery discipline. Being aware of the fact that bioactivity is not randomly dispersed in the vast chemical space, chemists have been developing hypothesis that can provide access to these islands of bioactivities. Natural products have always been a source of inspiration and their structural motifs provide biologically relevant starting points for library synthesis. In addition to that, Diversity Oriented Synthesis (DOS) and Biology Oriented Synthesis (BIOS) have emerged other tools to guide synthesis design and help enrich compound collections in biological activities. Coherent developments in chem- and bioinformatic tools and in organic synthesis methods targeting efficient synthesis of compound collections are required to identify interesting molecules that can be employed as probes in chemical biology research and as drug candidates in medicinal chemistry investigations.
Export Options
About this article
Cite this article as:
Eberhardt Luc, Kumar Kamal and Waldmann Herbert, Exploring and Exploiting Biologically Relevant Chemical Space, Current Drug Targets 2011; 12 (11) . https://dx.doi.org/10.2174/138945011798109482
DOI https://dx.doi.org/10.2174/138945011798109482 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Detection of Clonal Immunoglobulin and T-Cell Receptor Gene Recombination in Hematological Malignancies: Monitoring Minimal Residual Disease
Cardiovascular & Hematological Disorders-Drug Targets Synthesis of Novel Coumarin Derivatives 7,8-Fused onto Thiazole
Letters in Organic Chemistry Subcellular Trafficking in Rhabdovirus Infection and Immune Evasion: A Novel Target for Therapeutics
Infectious Disorders - Drug Targets Antimitotic Chalcones and Related Compounds as Inhibitors of Tubulin Assembly
Anti-Cancer Agents in Medicinal Chemistry New Perspective on the Dual Functions of Indirubins in Cancer Therapy and Neuroprotection
Anti-Cancer Agents in Medicinal Chemistry New Medical Strategies for Midgut Carcinoids
Anti-Cancer Agents in Medicinal Chemistry Methodological Aspects and Applications of In Vivo Imaging of Apoptosis in Oncology: An Illustrative Review
Current Medical Imaging The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes
Current Clinical Pharmacology Kavalactone Pharmacophores for Major Cellular Drug Targets
Mini-Reviews in Medicinal Chemistry Pathobiology and Therapeutic Implications of Tumor Acidosis
Current Medicinal Chemistry 2-Arylbenzimidazoles as Antiviral and Antiproliferative Agents-Part 2
Medicinal Chemistry Palifermin in theManagement of Mucositis in Hematological Malignancies: Current Evidences and Future Perspectives
Cardiovascular & Hematological Agents in Medicinal Chemistry Diterpenoids from Liverworts and their Biological Activities
Current Organic Chemistry Lead Generation for Human Mitotic Kinesin Eg5 Using Structure-based Virtual Screening and Validation by In-vitro and Cell-based Assays
Current Computer-Aided Drug Design Role of the Bone Marrow Microenvironment in Drug Resistance of Hematological Malignances
Current Medicinal Chemistry Antitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy
Current Pharmaceutical Design In Situ Gene Therapy for Prostate Cancer
Current Gene Therapy A Patent Review on the Use of L-Asparaginase in the Treatment of Acute Lymphocytic Leukemia
Recent Advances in Drug Delivery and Formulation MicroRNA in Multiple Myeloma - A Role in Pathogenesis and Prognostic Significance
Current Medicinal Chemistry Recent Kinase and Kinase Inhibitor X-ray Structures: Mechanisms of Inhibition and Selectivity Insights
Current Medicinal Chemistry